1. Introduction
===============

Pyrazoles and their variously substituted derivatives are important biological agents and a significant amount of research activity has been directed towards this class. In particular, they are used as antitumor \[[@B1-molecules-17-04962]\], antibacterial and antifungal, antiviral, antiparasitic, anti-tubercular and insecticidal agents \[[@B2-molecules-17-04962],[@B3-molecules-17-04962],[@B4-molecules-17-04962],[@B5-molecules-17-04962],[@B6-molecules-17-04962],[@B7-molecules-17-04962],[@B8-molecules-17-04962],[@B9-molecules-17-04962],[@B10-molecules-17-04962]\]. Some of these compounds have also anti-inflammatory, anti-diabetic, anesthetic and analgesic properties \[[@B11-molecules-17-04962],[@B12-molecules-17-04962],[@B13-molecules-17-04962],[@B14-molecules-17-04962]\]. Moreover, chalcones have played a crucial part in the development of theory of heterocyclic compounds, and also they used extensively in organic synthesis \[[@B15-molecules-17-04962],[@B16-molecules-17-04962],[@B17-molecules-17-04962],[@B18-molecules-17-04962],[@B19-molecules-17-04962]\]. A classical synthesis of these compounds involves the base-catalyzed aldol condensation reaction of ketones and aldehydes to give *α*,*β*-unsaturated ketones (chalcones), which undergo a subsequent cyclization reaction with hydrazines affording pyrazoles \[[@B11-molecules-17-04962],[@B20-molecules-17-04962],[@B21-molecules-17-04962],[@B22-molecules-17-04962]\]. In recent years, a significant portion of research in heterocyclic chemistry has been devoted to pyrazoles containing different aryl groups, as evident from the literature \[[@B23-molecules-17-04962],[@B24-molecules-17-04962],[@B25-molecules-17-04962],[@B26-molecules-17-04962],[@B27-molecules-17-04962],[@B28-molecules-17-04962],[@B29-molecules-17-04962],[@B30-molecules-17-04962]\].

2. Results and Discussion
=========================

A convenient route for the synthesis of *α*,*β*-unsaturated ketones **1a**--**e** is achieved by base catalyzed condensation of benzyl methyl ketone with the appropriate *p*-substituted benzaldehyde in the presence of piperidine \[[@B31-molecules-17-04962]\] ([Scheme 1](#molecules-17-04962-f001){ref-type="scheme"}).

![Synthesis of compounds **1a**--**e**, **2a**--**e**, **3a**--**e**, **4a**--**e**, **5a**--**e**.](molecules-17-04962-g001){#molecules-17-04962-f001}

The *(E)-*Configuration for **1a**--**e** comes from ^1^H-NMR measurements where the vinyl proton of the *(E)-*isomer appears at relatively higher field than the *(Z)-*one \[[@B32-molecules-17-04962]\]. The hydrazone derivatives **2a**--**e** were obtained in good yields by heating **1a**--**e** with *p*-sulphamylphenyl hydrazine in ethanol containing few drops of glacial acetic acid. The IR of **2a**--**e** showed the characteristic bands for C=N at 1,626--1,633, and primary and secondary amine bands at 3,379--3,391 and 3,289--3,310 cm^−1^, respectively. The ^1^H-NMR spectra showed the presence of a singlet equivalent to one proton in the range δ = 8.21--8.73 ppm characteristic for a hydrazone NH proton, while the primary amine NH~2~ protons appeared at δ = 9.23--9.40 ppm, a multiplet at δ = 7.31--7.82 ppm characteristic for the aromatic protons, a singlet at δ = 6.89--6.97 ppm for N=C--C=CH and a singlet equivalent to three protons at δ = 2.19--2.37 ppm characteristic for N=C-CH~3~ protons. Treatment of **2a**--**e** with 30% HCl produced the pyrazole derivatives **3a**--**e** in good yields.

The IR of **3a**--**e** showed the characteristic bands for C=N at 1,632--1,656, C=C at 1,500--1,520 whereas NH~2~ band appeared at 3,378--3,393 cm^−1^. The ^1^H-NMR spectra for **3a**--**e** revealed the following signals: A singlet equivalent to two exchangeable protons at δ = 9.33--10.37 ppm characteristic for NH~2~ protons, a multiplet at δ = 7.13--8.29 ppm characteristic for the aromatic protons. The methyl protons at C~3~ of the pyrazole ring appeared as a singlet at δ 2.22--2.28 ppm. In the case of **3b**, another singlet appeared at δ = 3.34 ppm characteristic for OCH~3~ group at the *p*-position to phenyl group. Finally, condensation of **1a**--**e** with either thiosemicarbazide or isonicotinic acid hydrazide in ethanol containing few drops of acetic acid gave pyrazolines **4a**--**e** or **5a**--**e**, respectively. The pyrazoline structures were fully confirmed by spectral and elemental analyses methods ([Table 1](#molecules-17-04962-t001){ref-type="table"} and [Table 2](#molecules-17-04962-t002){ref-type="table"}). The IR spectra of **4a**--**e** lacked the carbonyl band but showed a thiocarbonyl band at 1,232--1,248 and primary and secondary amine absorption bands at 3,387--3,394 and 3,282--3,316 cm^−1^ respectively. On the other hand the IR of **5a**--**e** showed an amide carbonyl band at 1,628--1,634 cm^−1^ and a primary amine absorption band only. The ^1^H-NMR of either **4a**--**e** or **5a**--**e** revealed the presence of an exchangeable hydrogen of one proton intensity for a NH proton at δ = 8.26--8.48 ppm or 8.31--8.51 ppm, respectively. In the case of **4a**--**e**, another exchangeable hydrogens of two protons intensity was also appeared at δ = 10.71--10.93 ppm characteristic for thiocarboxamide protons (S=C--NH~2~). The pyrazole-C~5~-H for **4a**--**e** and **5a**--**e** appeared as a singlet at δ = 5.39--5.46 ppm and 5.37--5.47 ppm, respectively.
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###### 

Physical and analytical data of compounds **2a**--**e**, **3a**--**e**, **4a**--**e**, and **5a**--**e**.

  Compound   R        Yield   M.P.   Molecular Formula       Calculated %   Found %                          
  ---------- -------- ------- ------ ----------------------- -------------- --------- ------- ------- ------ -------
  **2a**     H        67      147    C~22~H~21~N~3~SO~2~     67.52          5.37      10.74   67.50   5.40   10.70
  **2b**     OCH~3~   90      160    C~23~H~23~N~3~SO~3~     65.56          5.46      9.98    65.60   5.44   9.95
  **2c**     Cl       87      103    C~22~H~20~N~3~SO~2~Cl   61.97          4.69      9.86    61.94   4.66   9.90
  **2d**     Br       93      110    C~22~H~20~N~3~SO~2~Br   56.17          4.26      8.94    56.20   4.30   8.97
  **2e**     NO~2~    79      135    C~22~H~20~N~4~SO~4~     60.55          4.59      12.84   60.50   4.63   12.80
  **3a**     H        69      187    C~22~H~19~N~3~SO~2~     67.87          4.88      10.80   67.84   4.92   10.84
  **3b**     OCH~3~   91      193    C~23~H~21~N~3~SO~3~     65.87          5.01      10.02   65.90   5.05   10.06
  **3c**     Cl       76      172    C~22~H~18~N~3~SO~2~Cl   62.26          4.25      9.91    62.30   4.21   9.94
  **3d**     Br       78      177    C~22~H~18~N~3~SO~2~Br   56.41          3.85      8.97    56.45   3.90   8.95
  **3e**     NO~2~    69      197    C~22~H~18~N~4~SO~4~     60.83          4.15      12.90   60.80   4.15   12.94
  **4a**     H        81      149    C~17~H~17~N~3~S         69.15          5.76      14.24   69.10   5.76   14.20
  **4b**     OCH~3~   83      156    C~18~H~19~N~3~SO        66.46          5.85      12.92   66.50   5.85   12.95
  **4c**     Cl       87      172    C~17~H~16~N~3~SCl       61.82          4.85      12.73   61.86   4.88   12.69
  **4d**     Br       79      146    C~17~H~16~N~3~SBr       54.55          4.28      11.23   54.50   4.29   11.20
  **4e**     NO~2~    93      166    C~17~H~16~N~4~SO~2~     60.00          4.71      16.47   59.99   4.66   16.43
  **5a**     H        81      159    C~22~H~19~N~3~O         77.42          5.57      12.32   77.45   5.59   12.36
  **5b**     OCH~3~   69      166    C~23~H~21~N~3~O~2~      74.39          5.66      11.32   74.35   5.69   11.30
  **5c**     Cl       89      142    C~22~H~18~N~3~OCl       70.21          4.79      11.17   70.25   4.74   11.24
  **5d**     Br       86      168    C~22~H~18~N~3~OBr       62.86          4.29      10.00   62.82   4.25   10.05
  **5e**     NO~2~    97      171    C~22~H~18~N~4~O~3~      68.39          4.66      14.51   68.44   4.60   14.55

molecules-17-04962-t002_Table 2

###### 

IR and ^1^H-NMR spectral data of compounds **2a**--**e**, **3a**--**e**, **4a**--**e**, and **5a**--**e**.

  Compound   IR cm^−1^ (KBr)   ^1^H-NMR (δ / ppm) ^a^                                                                                        
  ---------- ----------------- ------------------------ ------ ------ ------------ --------------------------- ------ ------ --------------- ----------------
  **2a**     1603              1632                     \-     \-     3391, 3291   7.33--7.82                  6.91   \-     2.33            8.21 and 9.23
  **2b**     1609              1629                     \-     \-     3389, 3309   7.31--7.81                  6.93   \-     2.22 and 3.26   8.46 and 9.29
  **2c**     1612              1626                     \-     \-     3382, 3289   7.36--7.61                  6.97   \-     2.22            8.54 and 9.31
  **2d**     1604              1633                     \-     \-     3383, 3302   7.41--7.71                  6.89   \-     2.19            8.61 and 9.39
  **2e**     1619              1627                     \-     \-     3379,3310    7.26--7.76                  6.95   \-     2.37            8.73 and 9.40
  **3a**     1515              1632                     \-     \-     3386         7.24--8.29                  \-     \-     2.25            9.33
  **3b**     1510              1641                     \-     \-     3384         7.35--7.94                  \-     \-     2.28 and 3.34   9.76
  **3c**     1500              1644                     \-     \-     3378         7.29--7.86                  \-     \-     2.22            9.92
  **3d**     1515              1654                     \-     \-     3391         7.13--7.64                  \-     \-     2.25            9.71
  **3e**     1520              1656                     \-     \-     3393         7.29--8.10                  \-     \-     2.28            10.37
  **4a**     1527              \-                       \-     1246   3394, 3287   7.26--7.82                  \-     5.39   2.25            10.73 and 8.26
  **4b**     1522              \-                       \-     1245   3390, 3293   7.27--7.77                  \-     5.42   2.32 and 3.39   10.77 and 8.37
  **4c**     1531              \-                       \-     1248   3390, 3282   7.29--8.01                  \-     5.44   2.27            10.79 and 8.42
  **4d**     1527              \-                       \-     1247   3393, 3311   7.23--7.61                  \-     5.46   2.29            10.93 and 8.43
  **4e**     1526              \-                       \-     1232   3387, 3316   7.27--7.99                  --     5.39   2.32            10.71 and 8.48
  **5a**     1517              \-                       1630   \-     3291         6.81--7.09 and 7.32--7.48   \-     5.40   2.32            8.31
  **5b**     1530              \-                       1628   \-     3293         6.79--7.12 and 7.29--7.49   \-     5.37   2.25 and 3.31   8.36
  **5c**     1522              \-                       1631   \-     3287         6.83--7.08 and 7.27--7.51   \-     5.46   2.27            8.45
  **5d**     1519              \-                       1633   \-     3289         6.82--7.11 and 7.27--7.52   \-     5.47   2.22            8.47
  **5e**     1524              \-                       1634   \-     3311         6.84--7.10 and 7.26--7.71   \-     5.42   2.39            8.51

^a^ Solution in DMSO-*d~6~*.

2.1. Antimicrobial Activity
---------------------------

All of our compounds, *i.e*., hydrazones **2a**--**e**, pyrazoles **3a**--**e**, pyrazolines **4a**--**e** and **5a**--**e** were tested for antimicrobial activity against four test organisms: *Staphylococcus aureus* ATCC6538P, *Escherichia coli* ATCC873, *Pseudomonas aeruginosa* ATCC9027 and *Candida albicans* ATCC2091 using rifampicin (5 μg/disc) and ampicillin (10 μg/disc) as standard drugs ([Table 3](#molecules-17-04962-t003){ref-type="table"}).

molecules-17-04962-t003_Table 3

###### 

Antimicrobial activities of all the synthesized compounds.

  Compound         Zone of inhibition (mm)   Minimum inhibition concentration (MIC) g/mL         
  ---------------- ------------------------- --------------------------------------------- ----- -----
  **2a**           \-                        20                                            \-    250
  **2b**           \-                        15                                            \-    \-
  **2c**           17                        20                                            100   50
  **2d**           14                        20                                            120   500
  **2e**           12                        15                                            \-    \-
  **3a**           19                        22                                            63    31
  **3b**           18                        25                                            125   31
  **3c**           22                        26                                            50    50
  **3d**           18                        20                                            63    125
  **3e**           17                        17                                            \-    \-
  **4a**           \-                        15                                            \-    \-
  **4b**           \-                        15                                            \-    \-
  **4c**           21                        20                                            100   50
  **4d**           15                        18                                            63    63
  **4e**           \-                        15                                            \-    \-
  **5a**           \-                        15                                            \-    \-
  **5b**           \-                        15                                            \-    \-
  **5c**           21                        24                                            50    50
  **5d**           \-                        15                                            \-    \-
  **5e**           17                        17                                            \-    \-
  **Rifampicin**   32                        \-                                            \-    \-
  **Ampicillin**   30                        \-                                            \-    \-
  **DMSO**         \-                        14                                            \-    \-

(-) Indicates no activity.

The agar well-diffusion method \[[@B33-molecules-17-04962]\] was used for studying the potential activities of these compounds. All compounds only showed potent activity against *Staphylococcus aureus* and *Candida albicans* in the following ranking: **3a**--**e** \> **5a**--**e** \> **4a**--**e** ≥ **2a**--**e**. Minimum inhibitory concentration (MIC) values for the individual compounds that showed inhibition zones \> 10 were determined by means of the *agar well-diffusion* method in DMSO. The results of antimicrobial activities of our synthesized compounds against *S. aureus* and *C. albicans* are shown in [Table 3](#molecules-17-04962-t003){ref-type="table"} as zone of inhibition (in mm) and minimum inhibitory concentration, MIC (mg/mL). The trend of activity was observed as follows: X \> H \> OMe \> NO~2~ where X = Cl, Br. Minimum bactericidal concentrations (MBC) were determined for all chloro derivatives such as **1c**, **2c**, **3c**, **4c** and **5c** which exhibit good activities. These results are listed in [Table 4](#molecules-17-04962-t004){ref-type="table"}.
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###### 

Determination of minimum bactericidal concentration (MBC) µg/mL of chloro-derivatives.

  Concentrations µg/mL   1000   500   250   125   63   31   1000   500   250   125   63   31
  ---------------------- ------ ----- ----- ----- ---- ---- ------ ----- ----- ----- ---- ----
  **2c**                 \-     \-    \-    \+    \+   \+   \-     \-    \-    \-    \+   \+
  **3c**                 \-     \-    \-    \+    \+   \+   \-     \-    \-    \+    \+   \+
  **4c**                 \-     \-    \-    \+    \+   \+   \-     \-    \+    \+    \+   \+
  **5c**                 \-     \-    \+    \+    \+   \+   \-     \-    \-    \-    \+   \+

3. Experimental
===============

3.1. General
------------

Melting points were taken in open capillary tubes using an Electrothermal apparatus 9100 (Rochford, UK) and are uncorrected. Microanalyses were performed at Faculty of Science, Cairo University, Cairo, Egypt, using an Elementary Vario el III C, H, N, S analyzer (Hanau, Germany). IR spectra were recorded using potassium bromide disks on a Perkin Elmer Spectrum RXI/FT-IR System (Faculty of Pharmacy, Alexandria University, Alexandria, Egypt). ^1^H-NMR spectra were determined on a Varian EM-390 MHz spectrophotometer, using TMS as internal standard.

3.2. General Procedure for Preparation of 3-Phenyl-4-(p-substituted phenyl)-3-buten-1-ones ***1a**--**e***
----------------------------------------------------------------------------------------------------------

Compounds **1a**--**d** were obtained in a good yield according to a published method \[[@B31-molecules-17-04962]\]. The physical properties and all the spectral data were as reported in the literature

3.3. General Procedure for Preparation of 3-Phenyl-4-(p-substituted phenyl)-3-buten-1-(p-sulphamyl-phenyl)hydrazones ***2a**--**e***
------------------------------------------------------------------------------------------------------------------------------------

A solution of the chalcone **1a**--**e** (10 mmol) in ethanol (30 mL) was refluxed with the appropriate amount of *p*-sulphamylphenylhydrazine (10 mmol) in glacial acetic acid (2 mL) for six hours, then the reaction mixture was poured into crushed ice and kept overnight at room temperature. The separated crude solid was filtered off, washed successively with water, dried and recrystallized from ethanol (95%) to give **2a**--**e** as needles. Physical and analytical data for the prepared compounds are shown in [Table 1](#molecules-17-04962-t001){ref-type="table"}. IR and ^1^H-NMR data are listed in [Table 2](#molecules-17-04962-t002){ref-type="table"}.

3.4. General Procedure for Preparation of 3-Methyl-4-phenyl-5-(p-substituted phenyl)-1-(p-sulphamyl-phenyl)pyrazoles ***3a**--**e***
------------------------------------------------------------------------------------------------------------------------------------

A mixture of the appropriate hydrazones **2a**--**e** (10 mmol) and 30% HCl (15 mL) was heated under reflux for three hours and left to cool. After the reaction mixture reached room temperature, it was poured into crushed ice and the oily product deposited was decanted from water and extracted with ether. The ether layer was washed two times by water, dried over anhydrous sodium sulphate and evaporated. The precipitate obtained was recrystallized from ethanol (95%) to afford the corresponding pyrazoles **3a**--**e** as needles. Physical and analytical data for **3a**--**e** are as shown in [Table 1](#molecules-17-04962-t001){ref-type="table"}. IR and ^1^H-NMR data are shown in [Table 2](#molecules-17-04962-t002){ref-type="table"}.

3.5. General Procedure for Preparation of 4,5-Dihydro-3-methyl-4-phenyl-5-(p-substituted phenyl)-pyrazole-1-thiocarboxamides ***4a**--**e***
--------------------------------------------------------------------------------------------------------------------------------------------

A mixture of the appropriate chalcone **1a**--**e** (10 mmol) in ethanol (30 mL) was refluxed with the appropriate amount of thiosemicarbazide (12 mmol) in glacial acetic acid (2 mL) for 17 hours, then the reaction mixture was poured into crushed ice and was kept overnight at room temperature. The separated crude solid was filtered off, washed successively with water, dried and recrystallized from ethanol/chloroform to give **4a**--**e** as needles. The results and characterization data are listed in [Table 1](#molecules-17-04962-t001){ref-type="table"} and [Table 2](#molecules-17-04962-t002){ref-type="table"}.

3.6. General Procedure for Preparation of 4,5-Dihydro-3-methyl-4-phenyl-5-(p-substituted phenyl)-1-isonicotinoylpyrazoles ***5a**--**e***
-----------------------------------------------------------------------------------------------------------------------------------------

A mixture of the appropriate chalcone **1a**--**e** (10 mmol) in ethanol (30 mL) was refluxed with the appropriate amount of isonicotinic acid hydrazide (10 mmol) in glacial acetic acid (2 mL) for five hours. The reaction mixture was treated as mentioned for the preparation of **4a**--**e** to give the corresponding pyrazole **5a**--**e**. Physical and spectroscopic data of **5a**--**e** are listed in [Table 1](#molecules-17-04962-t001){ref-type="table"} and [Table 2](#molecules-17-04962-t002){ref-type="table"}, respectively.

3.7. Determination of Antimicrobial Activity
--------------------------------------------

All compounds were tested against four different microorganisms: *Staphylococcus aurous*, Escherichia *coli*, *Pseudomonas aeruginosa* and *Candida albicans.* The agar well-diffusionmethod was applied for the determination of inhibition zone and minimum inhibitory concentration (MIC). Briefly, broth culture (0.75 mL) containing *ca*. 10^6^ colon-forming units (CFU) per mL of the test strain was added to nutrient agar medium (75 mL) at 45 °C, mixed well, and then poured into a 15 cm sterile metallic Petri plate. The medium was allowed to solidify and 8 mm wells were dug with a sterile metallic borer, then a DMSO solution of the test sample (1 mL) at 1 mg/mL was added to the respective wells. DMSO served as negative control, and the standard antimicrobial drugs rifampicin (5 μg/disc) and ampicillin (10 μg/disc) were used as positive controls. Triplicate plates for each microorganism strain were prepared and were incubated aerobically at 37 °C for 24 h. The activity was determined by measuring the diameter of zone showing complete inhibition (mm), thereby, the zones were precisely measured with the aid of a Venier caliper (precision 0.1 mm). The growth inhibition was calculated with reference to the positive control. For the individual compounds that showed inhibition zones \>10 mm, MIC values were determined by means of the *agar well-diffusion* method for concentrations of 1.0, 0.50, 0.25, 0.125, 0.063 and 0.031 mg/mL in DMSO. The tests were performed in triplicate, and the results were averaged. Minimum bactericidal concentrations (MBC) were determined for all chloro derivatives which exhibit good activities (**1c**, **2c**, **4c** and **5c**) for concentrations of 1.0, 0.50, 0.25, 0.125, 0.063 and 0.031 mg/mL in DMSO. The results are listed in [Table 3](#molecules-17-04962-t003){ref-type="table"} and [Table 4](#molecules-17-04962-t004){ref-type="table"}.

4. Conclusions
==============

This work demonstrates a rapid, efficient method for synthesis of some pyrazole derivatives. Compounds having pharmacophores such as chloro- and bromo-substituents with lipophilic properties showed the greatest antimicrobial activity.
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